State Street
ODTX icon

State Street’s Odyssey Therapeutics ODTX Stock Holding History

State Street’s Portfolio ODTX Stock Details ODTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$6.87M Buy
309,293
+230,343
+292% +$4.89M ﹤0.01% 2901
2026
Q2 		$1.48M Buy
+78,950
New +$1.38M ﹤0.01% 3473

Other funds holding ODTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Lightspeed Management Company
Lightspeed Management Company Menlo Park, California $2.03B AUM 10.68% 1-Year Est. Return
Sanofi
Sanofi Paris, France $630M AUM 104.49% 1-Year Est. Return
Affinity Asset Advisors
Affinity Asset Advisors New York $2.46B AUM 196.28% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Sands Capital Ventures
Sands Capital Ventures Arlington, Virginia $695M AUM 31.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vivo Capital
Vivo Capital Palo Alto, California $909M AUM 385.65% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return

State Street's ODTX Position: Q3 2026 in Review

State Street increased its Odyssey Therapeutics (ODTX) stake by 292% in Q3 2026, buying an estimated $4.89M and bringing the position to 309,293 shares worth $6.87M. The position accounts for ﹤0.01% of the portfolio, ranked #2901.

State Street first reported a position in ODTX in Q2 2026 and has held it in 2 quarters since. 41 funds tracked by Wall St. Rank hold ODTX as of Q3 2026.

  • State Street held 309,293 shares of Odyssey Therapeutics worth $6.87M as of Q3 2026.
  • State Street bought 230,343 Odyssey Therapeutics shares in Q3 2026, an estimated $4.89M.
  • Odyssey Therapeutics made up ﹤0.01% of State Street's portfolio in Q3 2026, its #2901 holding.
  • State Street first reported a position in Odyssey Therapeutics in Q2 2026 and has held it in 2 quarters since.
  • 41 funds tracked by Wall St. Rank held Odyssey Therapeutics as of Q3 2026.

Based on State Street's 13F filing for Q3 2026, filed 12 Nov 2026.